Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Umakanth Vudumula"'
Autor:
Virender Bhan, Fraser Clift, Moogeh Baharnoori, Kimberly Thomas, Barkha P Patel, Francois Blanchette, Nicholas Adlard, Umakanth Vudumula, Kapil Gudala, Nikkita Dutta, Daniel Grima, Soukaina Mouallif, Fatine Farhane
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 9 (2023)
Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle l
Externí odkaz:
https://doaj.org/article/28912569120748138041870a3a8c4948
Publikováno v:
Journal of medical economics.
ObjectivesTo evaluate the impact of early (at first-line) vs delayed (3-year delay) ofatumumab initiation and long-term clinical, societal, and economic outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis (RMS) patients from a Spa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd8cfd423102613c7f6a4ff0408fff1
https://pubmed.ncbi.nlm.nih.gov/36472139
https://pubmed.ncbi.nlm.nih.gov/36472139
Autor:
Philip Cooney, Farooq H. Maniyar, Pamela Vo, Umakanth Vudumula, Andriy Danyliv, Sreelatha Vadapalle, Jasper Huels, Peter J. Goadsby, Ronan Mahon, Andrea Lang
Publikováno v:
PharmacoEconomics. 39:357-372
Migraine is a common neurological disease that disproportionately affects females and has a peak incidence during productive years, resulting in significant burden. The aim of the study was to determine the cost effectiveness of erenumab for the prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36be83033ffa466675dc06040c5b2be
https://doi.org/10.1007/s40273-020-00996-2
https://doi.org/10.1007/s40273-020-00996-2
Autor:
Hamid Reza Nakhaipour, Umakanth Vudumula, Jean K. Mah, Robyn Schecter, Nicholas Adlard, Guillaume Sébire, V. Khurana, Daniela Pohl
Publikováno v:
Journal of Medical Economics. 23:1525-1533
To evaluate the cost-effectiveness of fingolimod versus interferon (IFN)-β1a at a dose of 30 μg per week for the treatment of relapsing pediatric-onset multiple sclerosis (POMS) in Canada. A discrete-time Markov model was developed to compare fingo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b6ea7c3d324863b6b887debeec899a
https://doi.org/10.1080/13696998.2020.1840138
https://doi.org/10.1080/13696998.2020.1840138
Autor:
Dominik Koeditz, Juergen Frensch, Martin Bierbaum, Nils-Henning Ness, Benjamin Ettle, Umakanth Vudumula, Kapil Gudala, Nicholas Adlard, Santosh Tiwari, Tjalf Ziemssen
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical. 8(1)
Background Evidence suggests that early highly efficacious therapy in relapsing multiple sclerosis is superior to escalation strategies. Objective A cost-consequence analysis simulated different treatment scenarios with ofatumumab (OMB), dimethyl fum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::707d62214b543fef52d2c4f98dcb6dae
https://pubmed.ncbi.nlm.nih.gov/35371535
https://pubmed.ncbi.nlm.nih.gov/35371535
Autor:
Matthias Schwenkglenks, Kapil Gudala, Arjun Bhadhuri, Sreelatha Vadapalle, Nadine Schur, Nicholas Adlard, Umakanth Vudumula, Alain Casanova
Publikováno v:
Pharmacoeconomics
Objective The study aim was to evaluate the cost effectiveness and budget impact of siponimod compared to interferon beta-1a for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease, from a Swiss health insurance pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73ce8ed8ae94487b8e631103b753cda
Autor:
Andriy Danyliv, Pamela Vo, Peter J. Goadsby, Ronan Mahon, Philip Cooney, Victoria Hacking, Farooq H. Maniyar, Umakanth Vudumula, Jasper Huels, Stephen Palmer, Sreelatha Vadapalle
Publikováno v:
Journal of medical economics. 23(8)
Background: For novel migraine therapies, economic evaluations will be required to understand the trade-offs between additional health benefit and additional cost. The purpose of this study was to conduct a systematic literature review (SLR) to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35db4a78fd4a9e27b2400c7506cd03e1
https://pubmed.ncbi.nlm.nih.gov/32285724
https://pubmed.ncbi.nlm.nih.gov/32285724
Autor:
S Bhattacharyya, Emilie Duchesneau, Jipan Xie, Eytan M. Stein, Umakanth Vudumula, Nanxin Li, Annie Guerin, Briana Ndife, George J Joseph, Gaetano Bonifacio
Publikováno v:
PharmacoEconomics. 37(2)
The aim of this study was to assess the cost effectiveness of midostaurin + cytarabine + daunorubicin (midostaurin arm) versus placebo + cytarabine + daunorubicin (placebo arm) in the treatment of adult patients with newly diagnosed FLT3-mutated acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd83d28f723fa32f7ca98c30e02dea3
https://pubmed.ncbi.nlm.nih.gov/30382485
https://pubmed.ncbi.nlm.nih.gov/30382485
Autor:
Aiyagari Ramesh, Manab Deb Adhikari, Biswa Ranjan Panda, Umakanth Vudumula, Arun Chattopadhyay
Publikováno v:
RSC Adv.. 2:1782-1793
In this study we report a new method for sensitive estimation of bacterial cells in solution based on a systematic decrease in the degree of poly-L-lysine (PLL)-mediated aggregation of gold nanoparticles (Au NPs). The quantification of cells was done
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d3364d59eca8b669dbcfe25d24a76e
https://doi.org/10.1039/c1ra01023a
https://doi.org/10.1039/c1ra01023a
Autor:
Umakanth Vudumula, Gopal Das, Aiyagari Ramesh, Bimlesh Ojha, Manab Deb Adhikari, Sudeep Goswami
Publikováno v:
RSC Advances. 2:3864
The overwhelming challenge posed by drug-resistant pathogenic bacteria underscores the need for potent bactericidal agents, which exhibit broad-spectrum activity and a mode of action that does not favor development of resistance. In the present study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfd5cdef2e6310cfc6440bcb31d18bfc
https://doi.org/10.1039/c2ra20140b
https://doi.org/10.1039/c2ra20140b